bms-986165
Showing 26 - 32 of 32
Ulcerative Colitis Trial in Worldwide (BMS-986165, Placebo)
Active, not recruiting
- Ulcerative Colitis
- BMS-986165
- Placebo
-
Bristol, Connecticut
- +106 more
Dec 22, 2022
Psoriasis Trial in Worldwide (BMS-986165, Placebo, Apremilast)
Completed
- Psoriasis
- BMS-986165
- +2 more
-
Birmingham, Alabama
- +163 more
Sep 1, 2021
Psoriasis Trial in Worldwide (BMS-986165, Placebo, Apremilast)
Completed
- Psoriasis
- BMS-986165
- +2 more
-
Birmingham, Alabama
- +204 more
Nov 29, 2021
Psoriasis Trial in Madison (BMS-986165)
Completed
- Psoriasis
- BMS-986165
-
Madison, WisconsinCovance Madison Clinical Research Unit
Feb 8, 2018
Autoimmune Diseases, Inflammatory Diseases Trial in Austin (BMS-986165, Rosuvastatin)
Completed
- Autoimmune Diseases
- Inflammatory Diseases
- BMS-986165
- Rosuvastatin
-
Austin, TexasPPD Phase I Clinic
Apr 13, 2017
Healthy Subjects Trial in Melbourne (BMS-986165, Interferon alpha-2a recombinant, Famotidine)
Completed
- Healthy Subjects
- BMS-986165
- +3 more
-
Melbourne, Victoria, AustraliaLocal Institution
Dec 23, 2016